Sarepta decision to halt Duchenne treatment continues to frustrate families; FDA reinstate a quarter of DOGE cuts; Contract research organizations report higher than expected pharma and biotech Q2 ...

John will offer his entrepreneurial and marketing insights on brand innovation to help healthcare marketers make a splash in a sea of change.

In a warning letter, the Food and Drug Administration said Glenmark Pharmaceuticals failed to properly investigate flaws with a generic drug that ProPublica found was linked to U.S. deaths.

With an eye on protecting consumers from those risks this summer, Band-Aid has launched its latest innovation: Waterproof ...

The FDA recently unveiled a new national priority voucher program that would seek to trade faster drug approvals for lower ...

The 10th annual conference featured sessions on leadership, becoming invaluable at work and developing a legacy through community.

Millions of people are expected to lose health insurance in the coming years as a result of the tax cut legislation Trump ...

Throughout the country, pediatricians say anxious parents are concerned about access to routine childhood immunizations, ...

IPG has launched Agentic Systems for Commerce (ASC), to help brands manage the complex commerce ecosystem. To optimize commerce performance, ASC leverages Interpublic’s proprietary agentic system, ...

UnitedHealth Group is complying with the DOJ’s criminal and civil investigations; Novartis to pay Matchpoint up to $1B to develop anti-inflammatory therapies; Roche looks at direct-to-patient sales in ...

A provision to end pharma's ad tax deductibility was dropped from the One Big Beautiful Bill but still remains firmly in D.C.’s crosshairs.